Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003464831 | SCV004206345 | pathogenic | Retinitis pigmentosa 39 | 2023-02-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003565687 | SCV004309999 | pathogenic | not provided | 2023-07-19 | criteria provided, single submitter | clinical testing | Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This sequence change creates a premature translational stop signal (p.Leu4058*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This premature translational stop signal has been observed in individual(s) with clinical features of Usher syndrome (PMID: 24944099, 29099798). For these reasons, this variant has been classified as Pathogenic. |